Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

amediplase

Known as: K2tu-PA 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
In this study, the in-vitro fibrinolytic efficacy of Tenecteplase, Amediplase and scu-PA was investigated in different external… Expand
Is this relevant?
2004
2004
Amediplase (K(2) tu-PA) is a hybrid plasminogen activator, consisting of the kringle 2 domain of alteplase and the protease… Expand
Is this relevant?
Review
2004
Review
2004
Amediplase, a chimeric protein containing functional domains of both tissue plasminogen activator and pro-urokinase plasminogen… Expand
Is this relevant?
2002
2002
  • BioDrugs : clinical immunotherapeutics…
  • 2002
  • Corpus ID: 971019
Amediplase [CGP 42935, MEN 9036, K2tu-PA] is a recombinant chimeric plasminogen activator, consisting of the kringle 2 domain… Expand
Is this relevant?
2002
2002
Third-generation plasminogen activators were developed in order to lengthen the half-life of the drug, to increase resistance to… Expand
Is this relevant?